Cargando…
The evolution of selective estrogen receptor modulators in osteoporosis therapy
Selective estrogen receptor modulators (SERMs), which exhibit estrogen receptor agonist or antagonist activity based on the target tissue, have evolved through multiple generations for the prevention and/or treatment of postmenopausal osteoporosis. An ideal SERM would protect bone without stimulatin...
Autor principal: | Hadji, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793274/ https://www.ncbi.nlm.nih.gov/pubmed/22853318 http://dx.doi.org/10.3109/13697137.2012.688079 |
Ejemplares similares
-
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Gennari, Luigi, et al.
Publicado: (2010) -
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Migliaccio, Silvia, et al.
Publicado: (2007) -
Selective Estrogen Receptor Modulators
por: An, Ki-Chan
Publicado: (2016) -
Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes
por: Smith, Carolyn L, et al.
Publicado: (2014) -
Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)